サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1652023

糖尿病装置の世界市場：市場規模・シェア・動向、業界分析 (種類別・流通チャネル別・最終用途別・地域別)、将来予測 (2025年～2034年)

Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
糖尿病装置の世界市場：市場規模・シェア・動向、業界分析 (種類別・流通チャネル別・最終用途別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年01月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の糖尿病装置市場規模は2034年までに673億9,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

糖尿病装置は、糖尿病を患う人々の血糖値の監視と維持、重篤な合併症の予防、一般的な生活の質の向上を支援します。このような積極的なアプローチは、疾病管理を強化し、患者の転帰を改善し、これらの機器が患者ケアの進歩に果たす重要な役割を明確にします。糖尿病装置市場の需要を牽引しているのは、糖尿病装置による入院や死亡率の減少効果です。

人工知能 (AI) や機械学習 (ML) などの先進技術が糖尿病装置に組み込まれていることが、糖尿病装置市場の収益拡大に大きく寄与しています。AIやMLは、根本的な危険因子を特定し、危険合併症を予測し、糖尿病網膜症や腎症などの糖尿病関連疾患を予防するための介入を提案するのに役立ちます。これらの技術はまた、生活習慣管理の改善、前向きな臨床判断の促進、患者エンゲージメントの向上に重要な役割を果たしています。例えば、2024年8月にNational Library of Medicineに掲載された研究では、AIと機械学習が糖尿病管理にますます活用され、予測精度、個別化された治療戦略、全体的な患者の転帰、ヘルスケア効率を大幅に改善していることが強調されています。

糖尿病装置メーカーは、高齢者人口の多さ、手頃な価格のヘルスケア、費用対効果の高い労働力、規制の緩さといった要因から、新興市場への進出を拡大しています。市場参入企業はまた、需要の増加に対応するため、先進的なインスリンポンプやペンなどの技術的進歩を活用しています。例えば、2022年6月、Abbott社は新しい持続グルコース・ケトン監視システムを発売し、市場での地位をさらに強化しました。

糖尿病装置市場：分析概要

種類別では、インスリン投与装置の分野が2024年の糖尿病装置市場シェアを独占しました。このセグメントの堅調な成長は、インスリンパッチ、ポンプ、自動インスリン送達 (AID) システムなどの著しい技術進歩によるものです。

流通チャネル別では、病院薬局セグメントが2024年の売上高シェア56.33％で市場をリードしました。これは、患者数が多く、病院薬局で革新的な新製品が入手可能なためです。

北米は、2024年の収益シェア41.80%で糖尿病装置市場を独占しました。高齢化人口の増加、ライフスタイルの変化による糖尿病罹患率の増加、肥満の有病率の増加など、さまざまな要因がこの地域の市場成長に寄与しています。

アジア太平洋の糖尿病装置市場は、予測期間中に7.45%の大幅なCAGRを記録すると予想されます。同地域の市場成長の原動力は、大手企業の存在と糖尿病罹患率の上昇です。さらに、血糖モニタリング技術の進歩が、予測期間中の同地域の市場拡大を促進すると期待されています。

同市場の主要企業の一例として、Abbott Diabetes Care社、B Braun Melsungen AG社、Biocorp社、DexCom社、Johnson &Johnson社、GlucoModicum社、LifeScan社、Medtronic PLC社、Molex社、Novo Nordisk社、Phillips-Medisize社、Roche Diabetes Care社、Senseonics社、Tandem Diabetes Care社などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 糖尿病装置市場の洞察

  • 市場スナップショット
  • 糖尿病装置の市場力学
    • 促進要因と機会
      • 新興国における糖尿病罹患率の上昇
      • 糖尿病装置の技術進歩
    • 抑制要因と課題
      • デバイスの高コスト
  • PESTLE分析
  • 糖尿病装置市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の糖尿病装置市場：種類別

  • 主な分析結果
  • イントロダクション
  • BGM (血糖モニタリング) 装置
  • インスリン投与装置

第6章 世界の糖尿病装置市場：流通チャネル別

  • 主な分析結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • 糖尿病クリニック/センター
  • オンライン薬局
  • その他

第7章 世界の糖尿病装置市場：最終用途別

  • 主な分析結果
  • イントロダクション
  • 病院
  • 診断センター
  • 在宅医療

第8章 世界の糖尿病装置市場：地域別

  • 主な分析結果
  • イントロダクション
    • 糖尿病装置市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：種類別 (2020～2034年)
    • 北米：流通チャネル別 (2020～2034年)
    • 北米：最終用途別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：種類別、2020-2034
    • 欧州：流通チャネル別 (2020～2034年)
    • 欧州：最終用途別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：種類別 (2020～2034年)
    • アジア太平洋：流通チャネル別 (2020～2034年)
    • アジア太平洋：最終用途別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：種類別 (2020～2034年)
    • 中東・アフリカ：流通チャネル別 (2020～2034年)
    • 中東・アフリカ：最終用途別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：種類別 (2020～2034年)
    • ラテンアメリカ：流通チャネル別 (2020～2034年)
    • ラテンアメリカ：最終用途別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Diabetes Care
  • B Braun Melsungen AG
  • Biocorp
  • DexCom, Inc.
  • Johnson & Johnson
  • GlucoModicum
  • LifeScan Inc.
  • Medtronic PLC
  • Molex
  • Novo Nordisk
  • Phillips-Medisize
  • Roche Diabetes Care
  • Senseonics, Inc.
  • Tandem Diabetes Care, Inc.
図表

List of Tables:

  • Table 1 Global Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 3 Global Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 6 North America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 US: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 8 US: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 US: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 12 Canada: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 18 UK: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 France: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 24 Germany: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 27 Italy: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 Spain: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 36 Russia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 China: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 48 India: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 54 Japan: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 South Korea: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 63 Australia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 UAE: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 78 Israel: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 South Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 87 Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Mexico: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 93 Brazil: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 96 Argentina: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Diabetes Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Diabetes Devices Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Diabetes Devices Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Diabetes Devices Market, by End Use, 2024 & 2034 (USD Billion)
  • Figure 12. Global Diabetes Devices Market Assessment, by Geography, 2020-2034 (USD Billion)
  • Figure 13. Strategic Analysis - Global Diabetes Devices Market
目次
Product Code: PM1326

The global diabetes devices market size is expected to reach USD 67.39 billion by 2034, according to a new study by Polaris Market Research. The report "Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use (Hospitals, Diagnostic Centers, and Homecare), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetes devices help people suffering from diabetes monitor and maintain blood sugar levels, prevent severe complications, and generally improve the quality of life. This proactive approach enhances disease management, improves patient outcomes, and underscores the significant role these devices play in advancing patient care. The diabetes devices market demand is driven by the effectiveness of diabetes devices in reducing hospitalizations and mortality rates.

The incorporation of advanced technologies such as artificial intelligence (AI) and machine learning (ML) in diabetes devices majorly contributes to the growing diabetes devices market revenue. AI and ML help identify underlying risk factors, predict risk complications, and suggest interventions to prevent diabetes-related conditions, such as diabetic retinopathy and nephropathy. These technologies also play a crucial role in improving lifestyle management, fostering positive clinical decisions, and increasing patient engagement. For instance, a study published in the National Library of Medicine in August 2024 highlights how AI and machine learning are being increasingly utilized in diabetes management, significantly improving predictive accuracy, personalized treatment strategies, overall patient outcomes, and healthcare efficiency.

Diabetes device manufacturers are expanding their presence into emerging markets due to factors such as a large elderly population, affordable healthcare, cost-effective labor, and less stringent regulations. Market participants are also capitalizing on technological advancements, including advanced insulin pumps and pens, to cater to the rising demand. For instance, in June 2022, Abbott launched a new continuous glucose and ketone monitoring system, further strengthening its position in the market.

Key Highlights of Diabetes Devices Market Report

Based on type, the insulin delivery devices segment dominated the diabetes devices market share in 2024. The segment's robust growth is attributed to significant technological advancements, such as insulin patches, pumps, and automated insulin delivery (AID) systems.

Based on distribution channel, the hospital pharmacies segment led the market with a revenue share of 56.33% in 2024. This is due to the high volume of patients and the availability of new innovative products in hospital pharmacies.

North America dominated the diabetes devices market with a revenue share of 41.80% in 2024. Various factors such as an rising aging population, increasing incidence of diabetes due to lifestyle changes, and growing prevalence of obesity contribute to the regional market growth.

The Asia Pacific diabetes devices market is expected to register a significant CAGR of 7.45% during the forecast period. The market growth in the region is driven by the presence of leading players and a rising incidence of diabetes. Additionally, advancements in blood glucose monitoring technology are expected to propel market expansion in the region during the forecast period.

A few of the key players in the market are Abbott Diabetes Care; B Braun Melsungen AG; Biocorp; DexCom, Inc.; Johnson & Johnson; GlucoModicum; LifeScan Inc.; Medtronic PLC; Molex; Novo Nordisk; Phillips-Medisize; Roche Diabetes Care; Senseonics, Inc.; and Tandem Diabetes Care, Inc.

Polaris Market Research has segmented the diabetes devices market report on the basis of type, distribution channel, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • BGM Devices
  • Self-Monitoring Devices
  • § Blood Glucose Meters
  • § Testing Strips
  • § Lancets
  • Continuous Glucose Monitoring Devices
  • § Sensors
  • § Transmitters
  • § Receiver
  • Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

  • Hospitals
  • Diagnostic Centers
  • Homecare

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of the Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Diabetes Devices Market Insights

  • 4.1. Diabetes Devices Market - Market Snapshot
  • 4.2. Diabetes Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Diabetes Prevalence in Developing Economies
      • 4.2.1.2. Technological Advancements in Diabetes Devices
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry Among Existing Firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Diabetes Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Diabetes Devices Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  • 5.3. BGM Devices
    • 5.3.1. Global Diabetes Devices Market, by BGM Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Self-Monitoring Devices
      • 5.3.2.1. Global Diabetes Devices Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Blood Glucose Meters
      • 5.3.2.2.1. Global Diabetes Devices Market, by Blood Glucose Meters, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Testing Strips
      • 5.3.2.3.1. Global Diabetes Devices Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
      • 5.3.2.4. Lancets
      • 5.3.2.4.1. Global Diabetes Devices Market, by Lancets, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Continuous Glucose Monitoring Devices
      • 5.3.3.1. Global Diabetes Devices Market, by Continuous Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
      • 5.3.3.2. Sensors
      • 5.3.3.2.1. Global Diabetes Devices Market, by Sensors, by Region, 2020-2034 (USD Billion)
      • 5.3.3.3. Transmitters
      • 5.3.3.3.1. Global Diabetes Devices Market, by Transmitters, by Region, 2020-2034 (USD Billion)
      • 5.3.3.4. Receiver
      • 5.3.3.4.1. Global Diabetes Devices Market, by Receiver, by Region, 2020-2034 (USD Billion)
  • 5.4. Insulin Delivery Devices
    • 5.4.1. Global Diabetes Devices Market, by Insulin Delivery Devices, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Pumps
      • 5.4.2.1. Global Diabetes Devices Market, by Pumps, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Pens
      • 5.4.3.1. Global Diabetes Devices Market, by Pens, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Syringes
      • 5.4.4.1. Global Diabetes Devices Market, by Syringes, by Region, 2020-2034 (USD Billion)
    • 5.4.5. Jet Injectors
      • 5.4.5.1. Global Diabetes Devices Market, by Jet Injectors, by Region, 2020-2034 (USD Billion)

6. Global Diabetes Devices Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Diabetes Devices Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Diabetes Devices Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.5. Diabetes Clinics/Centers
    • 6.5.1. Global Diabetes Devices Market, by Diabetes Clinics/Centers, by Region, 2020-2034 (USD Billion)
  • 6.6. Online Pharmacies
    • 6.6.1. Global Diabetes Devices Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Diabetes Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Diabetes Devices Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Diabetes Devices Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Diagnostic Centers
    • 7.4.1. Global Diabetes Devices Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Homecare
    • 7.5.1. Global Diabetes Devices Market, by Homecare, by Region, 2020-2034 (USD Billion)

8. Global Diabetes Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Diabetes Devices Market Assessment, by Geography, 2020-2034 (USD Billion)
  • 8.3. Diabetes Devices Market - North America
    • 8.3.1. North America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.3. North America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Diabetes Devices Market - US
      • 8.3.4.1. US: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Diabetes Devices Market - Canada
      • 8.3.5.1. Canada: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Diabetes Devices Market - Europe
    • 8.4.1. Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Diabetes Devices Market - UK
      • 8.4.4.1. UK: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Diabetes Devices Market - France
      • 8.4.5.1. France: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Diabetes Devices Market - Germany
      • 8.4.6.1. Germany: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Diabetes Devices Market - Italy
      • 8.4.7.1. Italy: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Diabetes Devices Market - Spain
      • 8.4.8.1. Spain: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Diabetes Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Diabetes Devices Market - Russia
      • 8.4.10.1. Russia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Diabetes Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Diabetes Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Diabetes Devices Market - China
      • 8.5.4.1. China: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Diabetes Devices Market - India
      • 8.5.5.1. India: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Diabetes Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Diabetes Devices Market - Japan
      • 8.5.7.1. Japan: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Diabetes Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Diabetes Devices Market - South Korea
      • 8.5.9.1. South Korea: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Diabetes Devices Market - Australia
      • 8.5.10.1. Australia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Diabetes Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Diabetes Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Diabetes Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Diabetes Devices Market - UAE
      • 8.6.5.1. UAE: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Diabetes Devices Market - Israel
      • 8.6.6.1. Israel: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Diabetes Devices Market - South Africa
      • 8.6.7.1. South Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Diabetes Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Diabetes Devices Market - Latin America
    • 8.7.1. Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Diabetes Devices Market - Mexico
      • 8.7.4.1. Mexico: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Diabetes Devices Market - Brazil
      • 8.7.5.1. Brazil: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Diabetes Devices Market - Argentina
      • 8.7.6.1. Argentina: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Diabetes Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Diabetes Care
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. B Braun Melsungen AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biocorp
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. DexCom, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Johnson & Johnson
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlucoModicum
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LifeScan Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Molex
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novo Nordisk
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Phillips-Medisize
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Roche Diabetes Care
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Senseonics, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Tandem Diabetes Care, Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development